We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

HYCOR BIOMEDICAL

HYCOR offers a comprehensive line of systems and testing products for in-vitro allergy and autoimmune disorders, incl... read more Featured Products: More products

Download Mobile App





Hycor Demonstrates Noveos Immunoanalyzer that Sets New Standards to Limit Impact of Interference

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Hycor Demonstrates Noveos Immunoanalyzer that Sets New Standards to Limit Impact of Interference (Photo courtesy of Hycor Biomedical)
Image: Hycor Demonstrates Noveos Immunoanalyzer that Sets New Standards to Limit Impact of Interference (Photo courtesy of Hycor Biomedical)

Hycor Biomedical (Garden Grove, CA, USA) demonstrated its new NOVEOS immunoanalyzer at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

Every year, the global laboratory medicine community comes together at AACC to collaborate and create system-wide changes that improve patient outcomes and enhance the quality of life for all. The exhibition provides a platform to connect with the industry leaders making ground-breaking advancements in laboratory medicine, including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, and lab management.

The NOVEOS immunoanalyzer has been designed to overcome challenges confronting laboratories routinely testing for allergen-specific IgE to aid in the diagnosis of allergic diseases. The system was designed to address common issues laboratorians face with current technologies by offering several innovative features, including a significant reduction in sample size, reduced blood-based interferences, less variability within allergen lots, increased accuracy and improved walk-away time for laboratory technicians.

NOVEOS IgE chemiluminescent immunoassay uses streptavidin-coated magnetic beads, a biotinylated capture allergen, serum sample and monoclonal anti-human IgE antibody. Only 4µL of patient sample volume is required which can be especially important in pediatric and geriatric sampling where it may be more difficult to retrieve larger samples. On-board reagents supply sufficient capacity for up to eight hours of continuous testing. This eliminates the need to continuously replenish materials throughout a typical work day. It allows maximum walk away time for laboratory technicians by allowing up to 75 tests per specific allergen and up to 140 allergens on the system at any time.

Many of the unrefined extracts that are used in skin-prick testing and competitive allergy assays generate less reliable patient results due to their complexity. As the allergen industry moves to more highly enriched or standardized extracts, the NOVEOS system has incorporated these materials to provide more consistent and accurate results. The advanced micro-particle technology limits interference from: Biotin, IgG / IgG4, and solid-phase related cross-reactive carbohydrate determinant (CCD). NOVEOS offers high sensitivity, excellent low-end precision and operates for up to 13 hours of true walk-away capability.

Related Links:
Hycor Biomedical 

Gold Supplier
Automated Immune Analyzer
UNION Immune Analyzer
New
Bench-Top Molecular Microarray System
NanoCHIP XL Analyzer
New
Undercounter Laboratory Refrigerator
iLR105-GX
New
Assayed Hemoglobin Control
https://www.eurotrol.com/en/spotlights/hemotrol-wb/

Print article
AACC

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.